Incyte Vs. Arcutis Biotherapeutics Industry Stock Comparison

Buy

55

INCY
Incyte

Last Price:

75.89

Seasonality Move:

37.85%

Sell

26

ARQT
Arcutis Biotherapeutics

Last Price:

9.25

Seasonality Move:

69.73%

Buy

55

Incyte (INCY) is a Buy

Is Incyte a Buy, Sell or Hold?

The current Incyte [INCY] share price is $75.87. The Score for INCY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
INCY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

26

Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

The current Arcutis Biotherapeutics [ARQT] share price is $9.26. The Score for ARQT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
ARQT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

INCY Stock Price Chart

What is Incyte's stock price today?

The Incyte share price today is $75.87
The current trend is moderately bullish and INCY is experiencing slight buying pressure.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

The Arcutis Biotherapeutics share price today is $9.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARQT is experiencing selling pressure, which indicates risk of future bearish movement.

INCY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	3.42	Buy
Relative Strength Index (14 RSI):	55.55	Buy
Chaikin Money Flow:	509919	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(66 - 79.28)	Buy
Bollinger Bands (100):	(60.65 - 71.63)	Buy

ARQT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.2	Buy
Relative Strength Index (14 RSI):	46.45	Sell
Chaikin Money Flow:	-1964555	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(8.47 - 10.11)	Sell
Bollinger Bands (100):	(8.96 - 10.46)	Sell

INCY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	80.36	Sell
20-day SMA:	74.29	Buy
50-day SMA:	68.89	Buy
200-day SMA:	61.74	Buy
8-day EMA:	78.42	Sell
20-day EMA:	75.46	Buy
50-day EMA:	70.72	Buy
200-day EMA:	64.37	Buy

ARQT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	10.23	Sell
20-day SMA:	9.24	Buy
50-day SMA:	9.65	Sell
200-day SMA:	9.4	Sell
8-day EMA:	9.89	Sell
20-day EMA:	9.63	Sell
50-day EMA:	9.56	Sell
200-day EMA:	9.12	Buy

Incyte Earnings Growth & INCY Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.29 per share, and an increase next year of $4.72 per share.

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.

Incyte Technical Analysis

	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15
	Nov
	04	05	06	07	08	11	12	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arcutis Biotherapeutics Technical Analysis

	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15
	Nov
	04	05	06	07	08	11	12	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):